FdaApplication

ANDA 209555

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNATCO PHARMA LTD
application_typeANDA
approval_date2023-05-15

Products (2)

ProductActive ingredientStrengthDosage form
TERIFLUNOMIDETERIFLUNOMIDE14MGTABLET;ORAL
TERIFLUNOMIDETERIFLUNOMIDE7MGTABLET;ORAL

2 products